Literature DB >> 6293034

Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro.

B Sugden.   

Abstract

Epstein-Barr virus (EBV) is a pathogen that is associated with several diseases in humans. It causes most heterophile-positive cases of infectious mononucleosis. The virus is associated with another lymphoproliferative disease, African Burkitt's lymphoma, and with a malignancy of the nasopharynx, nasopharyngeal carcinoma. EBV appears to be a causative agent for some fatal lymphoproliferations in congenitally immunodeficient people. One proliferating cell type in infectious mononucleosis is an EBV-infected B lymphoblast. The tumor cell in African Burkitt's lymphoma is also an EBV-infected B lymphoblast. In vitro, EBV induces and maintains blast transformation of human B lymphocytes. All EBV-transformed cells, whether infected in vivo or in vitro, share many (but not all) virus-associated characteristics. Studies can now be performed in vitro that permit analysis of the various EBV-transformed cells and the host's immune responses to them.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6293034     DOI: 10.1093/clinids/4.5.1048

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  7 in total

1.  Epstein-Barr virus nuclear antigen forms a complex that binds with high concentration dependence to a single DNA-binding site.

Authors:  G Milman; E S Hwang
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

2.  A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.

Authors:  J Yates; N Warren; D Reisman; B Sugden
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

3.  The capsid antigen of Epstein-Barr virus in nasopharyngeal carcinomas: comparison of serum antibody titre, cellular antigen content and histopathology.

Authors:  N Falser
Journal:  Arch Otorhinolaryngol       Date:  1984

4.  A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus.

Authors:  B Sugden; K Marsh; J Yates
Journal:  Mol Cell Biol       Date:  1985-02       Impact factor: 4.272

5.  Pathogenesis of Herpesvirus sylvilagus infection in cottontail rabbits.

Authors:  R M Hesselton; W C Yang; P Medveczky; J L Sullivan
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

6.  Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus.

Authors:  Fuqu Yu; Josephine N Harada; Helen J Brown; Hongyu Deng; Moon Jung Song; Ting-Ting Wu; Juran Kato-Stankiewicz; Christian G Nelson; Jeffrey Vieira; Fuyuhiko Tamanoi; Sumit K Chanda; Ren Sun
Journal:  PLoS Pathog       Date:  2007-03       Impact factor: 6.823

Review 7.  Comparative models for human nasal infections and immunity.

Authors:  Elisa Casadei; Irene Salinas
Journal:  Dev Comp Immunol       Date:  2018-12-01       Impact factor: 3.636

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.